Evidence map›Paper›PMID 33329949›Full record

ArticleCureus2020

The Prevalence of Beta-Blocker Use Among Medical Students at King Saud bin Abdulaziz University for Health Sciences in Jeddah, Saudi Arabia: A Cross-Sectional Study.

Rawan Alkhatabi, Joud Alowfi, Layan Arshad, Muhammad A Khan

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rawan AlkhatabiMedical Education, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Joud AlowfiMedical Education, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Layan ArshadMedical Education, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Muhammad A KhanEpidemiology and Public Health, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
King Saud bin Abdulaziz University for Health Sciences · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives The aim of this study was to evaluate the prevalence and patterns of beta-blocker usage among medical students. Reasons for the use and demographic factors influencing their consumption were also evaluated. Methods This was an observational cross-sectional study among medical students at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) Jeddah, Saudi Arabia. Medical students were surveyed between February and April of 2019 using an electronic self-administered questionnaire. The questionnaire had close-ended questions, 18 of which were about demographics and 17 about propranolol use. Results A total of 234 medical students participated in the study, of whom 14.5% (95% CI: 10.44-19.49) reported using propranolol. Fifth-year medical students comprised 50% of propranolol users. The prevalence of males using propranolol was lower compared to females. The most common reasons for using propranolol were anxiety relief and performance enhancement before the objective structured clinical exams (OSCEs; 70.6%) and before oral presentations (38.2%). Conclusion The prevalence of propranolol use among medical students in KSAU-HS Jeddah was low compared to other studies, with the highest reported use among fifth-year medical students. The main reasons for using propranolol were anxiety relief during OSCEs and performance enhancement for presentations. Efforts must be directed towards raising medical students' awareness of the risks of inappropriate beta-blocker use to decrease its use and avoid potential adverse effects of the medication.

Indexed as

beta blockersmedical studentspropranololsaudi arabia

Identifiers

PMID33329949
PMCPMC7733765
OpenAlexW3102833488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.